4-5

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Nektar's research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates.

Post : Research Associate II

P&G was founded over 180 years ago. Today, we're the world’s largest consumer goods company and home to iconic, trusted brands that make life a little bit easier in small but meaningful ways. We focus on Improving the lives of world Consumers. Procter & Gamble is the innovation leader in our industry. Virtually all the organic sales growth we’ve delivered in the past nine years has come from new brands and new or improved product innovation. We continually strengthen our innovation capability and pipeline by investing two times more, on average, than our major competitors. P&G. We interact with more than five million consumers each year in nearly 60 countries around the world. We conduct over 15,000 research studies every year. We invest more than $350 million a year in consumer understanding.

Post : Principal Scientist

CH.SUGHAR SINGH EDUCATIONAL GROUP was established under the Trust of CH. SUGHAR SINGH SMRITI NYAS in the year of 2002 The group is providing excellence education to undergraduate, graduate and post-graduate students. CSSGI is an attempt to serve the ends of technological excellence which is the desire of mankind CH. SUGHAR SINGH SMRITI NYAS is a registered trust by Government of U.P. The trust was formed with the goal to provide better education in rural and down trodden areas.

Post : Assistant Professor

The Dr. Reddy's Institute of Life Sciences was conceived in the context of globalization, to foster research competence in India and to bridge the divide between academic research and the pharmaceutical & biotechnology industries. The institute was incorporated as a non-profit entity under Section 25 of the Indian companies act, facilitating operational autonomy. Construction of the DRILS building comprising 44 labs and an administrative block and spanning ~130,000 sq.ft. in area, began in 2004 and was completed in January 2007.

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Analyst - Artwork Ops

Johnson & Johnson is the world’s most comprehensive and broadly based manufacturer of health care products. The organization is comprised of more than 250 operating companies with over 120,000 employees located in some 60 countries. With Global sales of USD 81.6 billion in 2018, Johnson & Johnson is recognized as one of the most admired and respected companies in the world.

Post : Regional Account Manager

Par is a pharmaceutical company that develops, manufacturers and markets safe, innovative and cost-effective pharmaceuticals that help improve patient quality of life. Par Pharmaceutical offers a line of high-barrier-to- entry generic drugs. We offer a wide variety of interesting employment opportunities and are continually looking for key external talent to complement our existing workforce and enhance our organizational strength, adding the diversity required to continue along our successful path.

Aristo started its operations in 1971 with a manufacturing plant at Aurangabad, marketing operations in Mumbai with a field force of just 30 personnel. Since then Aristo has come a long way... From a turnover of US $ 8500 in 1971 to US $ 64 million in year 2000. The last few years have seen us blazing new trails and setting new standards in the pharmaceutical industry. The company has a formidable position in the industry. Sound infrastructure and well-qualified human force have helped Aristo to accomplish this achievement.

Aurobindo Pharma has identified international operations, catering to over 100 countries, as a major engine of growth and expanding global network of marketing and manufacturing operations across countries like China, Brazil, Japan, Netherlands, South Africa, Thailand, UK, USA, Russia, Netherlands and many more which will further expand its international reach.